UB Paderborn / Katalog / Suche / in CDI

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Journal of clinical oncology, 2012-06, Vol.30 (16), p.1989-1995

2012

Link zum Volltext

Verfügbarkeit prüfen

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials

BMC cancer, 2020-05, Vol.20 (1), p.418-418, Article 418

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

International journal of molecular sciences, 2024-02, Vol.25 (5), p.2490

2024

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Cancer management and research, 2018-01, Vol.10, p.91-103

2018

Link zum Volltext

Verfügbarkeit prüfen

Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma

Cell death & disease, 2023-10, Vol.14 (10), p.704-704, Article 704

2023

Link zum Volltext

Verfügbarkeit prüfen

Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist

Clinical breast cancer, 2022-06, Vol.22 (4), p.289-299

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients

Cancer biology & therapy, 2018-01, Vol.19 (10), p.879-886

2018

Link zum Volltext

Verfügbarkeit prüfen

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Annals of oncology, 2018-12, Vol.29 (12), p.2328-2333

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Frontiers in oncology, 2022-12, Vol.12, p.1016295-1016295

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature

Cancers, 2021-09, Vol.13 (19), p.4894

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting

Clinical breast cancer, 2023-10, Vol.23 (7), p.712-720.e3

2023

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis

Clinical breast cancer, 2023-12, Vol.23 (8), p.e534-e541

2023

Link zum Volltext

Verfügbarkeit prüfen

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

Oncotarget, 2018-08, Vol.9 (60), p.31606-31619

2018

Link zum Volltext

Verfügbarkeit prüfen

Palbociclib in a patient with HR+/HER2- advanced breast cancer and HIV1 infection: a case report

Breast cancer management, 2021-12, Vol.10 (4)

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors for Breast Cancer: an Immunomorphological Update

Pathology oncology research, 2016-07, Vol.22 (3), p.449-452

2016

Link zum Volltext

Verfügbarkeit prüfen

First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis

Clinical breast cancer, 2019-12, Vol.19 (6), p.e701-e716

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Cancer management and research, 2019-01, Vol.11, p.9563-9569

2019

Link zum Volltext

Verfügbarkeit prüfen

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Oncotarget, 2017-08, Vol.8 (34), p.56921-56931

2017

Link zum Volltext

Verfügbarkeit prüfen

Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status

Journal of cancer research and clinical oncology, 2019-04, Vol.145 (4), p.821-828

2019

Link zum Volltext

Verfügbarkeit prüfen

Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience

Future oncology (London, England), 2022-08, Vol.18 (24), p.2651-2659

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

BioMed research international, 2018-01, Vol.2018, p.3756981-8

2018

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the Diagnosis and Treatment of Acute and Subacute Rhinosinusitis in Children

Journal of chemotherapy (Florence), 2008-04, Vol.20 (2), p.147-157

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials

Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study

Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma

Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist

Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature

Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study

Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting

Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis

Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

Palbociclib in a patient with HR+/HER2- advanced breast cancer and HIV1 infection: a case report

Prognostic Factors for Breast Cancer: an Immunomorphological Update

First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis

Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status

Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

Guidelines for the Diagnosis and Treatment of Acute and Subacute Rhinosinusitis in Children

Aktive Filter

Suchergebnisse filtern